Hongying Dai1, Adam M Leventhal2. 1. Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, 984375 Nebraska Medical Center, Omaha, NE, 68198-4375, United States. Electronic address: daisy.dai@unmc.edu. 2. Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, United States; Department of Psychology, University of Southern California, Los Angeles, United States; USC Norris Comprehensive Cancer Center, Los Angeles, United States. Electronic address: adam.leventhal@usc.edu.
Abstract
BACKGROUND: Former combustible cigarette smokers who vape e-cigarettes after quitting smoking may experience health benefits if post-quit vaping prevents smoking relapse. METHODS: Former combustible cigarette smokers aged >18 that were recent (quit ≤ 12 months) or long-term (quit > 12 months) quitters at baseline were re-surveyed at 1-year follow-up in the Population Assessment of Tobacco and Health (PATH) U.S. nationally-representative longitudinal study. Associations of baseline e-cigarette vaping status (never use, prior use, current occasional use, and current regular use) and smoking relapse (vs. abstinence) at follow-up were estimated. RESULTS: Among recent quitters (N = 884), the prevalence of follow-up smoking relapse was 31.6%, 39.0%, 51.6%, and 31.9% among never (N = 233), prior (N = 399), current occasional (N = 56), and current regular (N = 196) baseline e-cigarette users, respectively. Baseline e-cigarette use was not associated with smoking relapse at follow-up after covariate adjustment. In long-term quitters (n = 3210), follow-up smoking relapse was 1.8%, 10.4%, 9.6%, and 15.0% among never (N = 2479), prior (N = 588), current occasional (N = 45), and current regular (N = 98) baseline e-cigarette users, respectively. Both prior use (AOR = 2.00, CI [1.25-3.20]) and current regular use of e-cigarettes (AOR = 3.77, CI [1.48-9.65]) had higher odds of subsequent smoking relapse as compared to never e-cigarette users after covariate adjustment. Among relapsers, baseline e-cigarette vaping was not associated with smoking frequency or intensity at follow-up. CONCLUSIONS: Vaping more than one year after quitting smoking was associated with smoking relapse at 12-month follow-up in a nationally-representative sample. Further studies are needed to evaluate whether this association is causal.
BACKGROUND: Former combustible cigarette smokers who vape e-cigarettes after quitting smoking may experience health benefits if post-quit vaping prevents smoking relapse. METHODS: Former combustible cigarette smokers aged >18 that were recent (quit ≤ 12 months) or long-term (quit > 12 months) quitters at baseline were re-surveyed at 1-year follow-up in the Population Assessment of Tobacco and Health (PATH) U.S. nationally-representative longitudinal study. Associations of baseline e-cigarette vaping status (never use, prior use, current occasional use, and current regular use) and smoking relapse (vs. abstinence) at follow-up were estimated. RESULTS: Among recent quitters (N = 884), the prevalence of follow-up smoking relapse was 31.6%, 39.0%, 51.6%, and 31.9% among never (N = 233), prior (N = 399), current occasional (N = 56), and current regular (N = 196) baseline e-cigarette users, respectively. Baseline e-cigarette use was not associated with smoking relapse at follow-up after covariate adjustment. In long-term quitters (n = 3210), follow-up smoking relapse was 1.8%, 10.4%, 9.6%, and 15.0% among never (N = 2479), prior (N = 588), current occasional (N = 45), and current regular (N = 98) baseline e-cigarette users, respectively. Both prior use (AOR = 2.00, CI [1.25-3.20]) and current regular use of e-cigarettes (AOR = 3.77, CI [1.48-9.65]) had higher odds of subsequent smoking relapse as compared to never e-cigarette users after covariate adjustment. Among relapsers, baseline e-cigarette vaping was not associated with smoking frequency or intensity at follow-up. CONCLUSIONS: Vaping more than one year after quitting smoking was associated with smoking relapse at 12-month follow-up in a nationally-representative sample. Further studies are needed to evaluate whether this association is causal.
Authors: Allison M Glasser; Mahathi Vojjala; Jennifer Cantrell; David T Levy; Daniel P Giovenco; David Abrams; Raymond Niaura Journal: Nicotine Tob Res Date: 2021-03-19 Impact factor: 4.244
Authors: Danielle M Smith; Carol Christensen; Dana van Bemmel; Nicolette Borek; Bridget Ambrose; Gladys Erives; Raymond Niaura; Kathryn C Edwards; Cassandra A Stanton; Benjamin C Blount; Lanqing Wang; Jun Feng; Jeffery M Jarrett; Cynthia D Ward; Dorothy Hatsukami; Stephen S Hecht; Heather L Kimmel; Mark Travers; Andrew Hyland; Maciej L Goniewicz Journal: Nicotine Tob Res Date: 2021-05-04 Impact factor: 4.244
Authors: David T Levy; Luz María Sánchez-Romero; Nargiz Travis; Zhe Yuan; Yameng Li; Sarah Skolnick; Jihyoun Jeon; Jamie Tam; Rafael Meza Journal: Int J Environ Res Public Health Date: 2021-05-03 Impact factor: 4.614
Authors: Ruifeng Chen; John P Pierce; Eric C Leas; Martha M White; Sheila Kealey; David R Strong; Dennis R Trinidad; Tarik Benmarhnia; Karen Messer Journal: Am J Epidemiol Date: 2020-12-01 Impact factor: 4.897
Authors: Rick Kosterman; Marina Epstein; Jennifer A Bailey; Madeline Furlong; J David Hawkins Journal: Drug Alcohol Depend Date: 2021-07-28 Impact factor: 4.852